Myocardial protection during myocardial revascularization: Preductal®MR
https://doi.org/10.21518/2079-701X-2013-9-98-100
Abstract
Myocardial revascularization procedures (coronary artery bypass surgery, percutaneous coronary intervention) raise the question of protecting the myocardium. Trimetazidine is an adequate method of myocardial protection. We discussed the use of trimetazidine in myocardial revascularization with Yuriy Mikhailovich Lopatin, MD, professor, head of subdepartment of cardiology and functional diagnostics at advanced medical training department of the Volgograd State Medical University.
Review
For citations:
Article E. Myocardial protection during myocardial revascularization: Preductal®MR. Meditsinskiy sovet = Medical Council. 2013;(9):98-100. (In Russ.) https://doi.org/10.21518/2079-701X-2013-9-98-100
Views:
353
Email this article 